Table: begin end state 1 11 cytoplasmic 12 29 transmembrane 30 35 non-cytoplasmic 36 55 transmembrane 56 94 cytoplasmic 95 115 transmembrane 116 120 non-cytoplasmic 121 142 transmembrane 143 162 cytoplasmic 163 186 transmembrane 187 193 non-cytoplasmic 194 212 transmembrane 213 223 cytoplasmic 224 244 transmembrane 245 258 non-cytoplasmic 259 279 transmembrane 280 286 cytoplasmic 287 307 transmembrane 308 327 non-cytoplasmic 328 348 transmembrane 349 367 cytoplasmic 368 388 transmembrane 389 467 non-cytoplasmic 468 487 transmembrane 488 512 cytoplasmic 513 532 transmembrane 533 544 non-cytoplasmic 545 569 transmembrane 570 575 cytoplasmic 576 598 transmembrane 599 645 non-cytoplasmic 646 669 transmembrane 670 688 cytoplasmic
Input: >PP_4641 MNNNNSLLRHIPWLALAVIGACALGVVALRRGEAINALWIVVAAVAIYLVAYRYYSLFIA TKVMQLDPRRATPAVLNNDGLDYVPTNKHILFGHHFAAIAGAGPLVGPVLAAQMGYLPGT LWLIAGVVLAGAVQDFMVLFLSTRRNGRSLGDMVREEMGRIPGTIALFGCFLIMIIILAV LALIVVKALAESPWGMFTVMATIPIAMFMGIYMRYIRPGRIGEISVVGVVLLLASIWLGG VIAADPVWGPAFTFTGVQITWMLVGYGFVAAVLPVWLVLAPRDYLSTFLKIGTILGLAIG ILIIAPELKMPALTQFTDGTGPVWKGTLFPFLFITIACGAVSGFHALISSGTTPKLLDNE TNARYIGYGGMLMESFVAIMAMVAASVIEPGVYFAMNSPAAVVGTDVASVAQTVSSWGFL ITPEQLEAVARDIGEHTILARAGGAPTLAVGIAQILHQVLPGENTMAFWYHFAILFEALF ILTAVDAGTRAGRFMLQDLLGSFVPALKRTESWGANLLATAGCVALWGYLLYQGVIDPLG GINTLWPLFGISNQMLAGIALMLGTVVLIKMKRQRYIWVTLLPAVWLLICTTAAGLIKLF DPNPAVGFLALAKKYSTALDAGQVLAPAKDIGQMQHVIFNAYTNAGLTILFLLVVFSILF FAIKVGYAALGRKERSDKETPFQALPDA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server